Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The update adds Revision: v3.4.2 and removes the earlier government-funding notice (v3.4.1), a minor maintenance update to the page.
    Difference
    0.5%
    Check dated 2026-02-11T09:25:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government-funding lapse notice was added, directing users to cc.nih.gov and opm.gov for updates. A new Revision: v3.4.1 banner replaces the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T05:42:10.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page includes minor UI/copy updates, including a new Show glossary option, capitalization tweaks (No FEAR Act data; Last Update Submitted that Met QC Criteria), and a Revision: v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:21:20.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T01:25:24.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer updates include removal of HHS Vulnerability Disclosure and addition of Revision: v3.3.3; these are minor site maintenance updates and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T22:31:47.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page. No visible changes to the study details.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.